Literature DB >> 7993403

Impairment of consciousness induced by valproate treatment following neurosurgical operation.

J Landau1, M Baulac, G Durand, A de Billy, J Philippon.   

Abstract

Eight patients, who underwent neurosurgery for various supratentorial lesions presented unexplained impairment of consciousness during the first post-operative days. These states ranged from stupor to deep coma, and two patients had an emergency re-exploration. All these patients were receiving the usual dosage (1000 to 1500 mg per day) of Valproic acid (VPA). The treatment had been initiated either several weeks or months previously in 4 cases, and was thus well tolerated, or the day before surgery in the 4 other cases. EEG recordings displayed diffuse abnormalities, delta waves and/or high voltage triphasic complexes, that led to the diagnosis of VPA intolerance and drug withdrawal. Then full clinical recovery and EEG clearing occurred within 1 to 5 days. VPA intolerances are wellknown but remain exceptional, about 1 case per 100.000. In our neurosurgical population, however, the rate was higher, approximately 2%. Wide areas of blood brain barrier destruction may contribute to the higher frequency of this easily reversible cause of post-operative stupor or coma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7993403     DOI: 10.1007/BF01401834

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  14 in total

1.  Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.

Authors:  D L Coulter; R J Allen
Journal:  Lancet       Date:  1980-06-14       Impact factor: 79.321

2.  Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction.

Authors:  B S Zaret; R R Beckner; A M Marini; W Wagle; C Passarelli
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

3.  [Isolated hyperammonemia. A frequent consequence of treatment with sodium valproate].

Authors:  J M Warter; C Marescaux; L Rumbach; J Galmiche; G Micheletti; C Koehl; M Imler
Journal:  Nouv Presse Med       Date:  1981-11-14

4.  Valproate-induced coma with ketosis and carnitine insufficiency.

Authors:  W J Triggs; T P Bohan; S N Lin; L J Willmore
Journal:  Arch Neurol       Date:  1990-10

5.  Acute intoxication with sodium valproate.

Authors:  D W Chadwick; W J Cumming; I Livingstone; N E Cartlidge
Journal:  Ann Neurol       Date:  1979-12       Impact factor: 10.422

6.  Electroencephalographic alterations during intoxication with sodium valproate: a case report.

Authors:  B Pedersen; P Juul-Jensen
Journal:  Epilepsia       Date:  1984-02       Impact factor: 5.864

7.  Hyperammonemia and valproate-induced alterations of the state of consciousness. A report of 8 cases.

Authors:  G Zaccara; M Paganini; R Campostrini; G Arnetoli; R Zappoli; F Moroni
Journal:  Eur Neurol       Date:  1984       Impact factor: 1.710

Review 8.  [Late diagnosis of congenital argininemia during administration of sodium valproate].

Authors:  D Christmann; E Hirsch; V Mutschler; M Collard; C Marescaux; J P Colombo
Journal:  Rev Neurol (Paris)       Date:  1990       Impact factor: 2.607

9.  Valproic acid and secondary hyperammonemia.

Authors:  S Rawat; W J Borkowski; H M Swick
Journal:  Neurology       Date:  1981-09       Impact factor: 9.910

10.  [Severe vigilance disturbances: a rare complication of sodium valproate treatment (author's transl)].

Authors:  B Cenraud; B Pautrizel; O Berets; P Loiseau
Journal:  Rev Electroencephalogr Neurophysiol Clin       Date:  1980 Oct-Dec
View more
  1 in total

Review 1.  Hyperammonemic coma after craniotomy: Hepatic encephalopathy from upper gastrointestinal hemorrhage or valproate side effect?: Case report and literature review.

Authors:  Xiaopeng Guo; Junji Wei; Lu Gao; Bing Xing; Zhiqin Xu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.